Hepatobiliary Cancer
Contact: CancerResearch@VirginiaMason.org ; (206) 287-6270
Clinical Studies | Diagnosis | |||
---|---|---|---|---|
Non-Metastatic | Metastatic | Previously Treated | Treatment Naive | |
✔ | ✔ | |||
✔ | ✔ | |||
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEY NOTE-937) | ✔ | ✔ | ||
A Phase 2, Multicenter, Clinical Study to Evaluate the Safety and Efficacy of MK-1308A (Coformulated MK-1308/MK-3475) in Combination with Lenvatinib (E7080/MK-7902) in First-line Therapy of Participants with Advanced Hepatocellular Carcinoma | ||||
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Subjects With Primary Sclerosing Cholangitis | ✔ | ✔ | ||
VM BRITE: A Tissue Registry and Specimen Repository to Support Future Research Projects | ✔ | ✔ | ✔ | ✔ |